LIPS-A: Lung Injury Prevention Study With Aspirin

NCT01504867 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Distress Syndrome

Interventions

DRUG: Aspirin
DRUG: Lactose powder

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]